{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:14:29Z","timestamp":1753892069435,"version":"3.41.2"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Brown-Vialetto-Van Laere (BVVL) syndrome is an extremely rare autosomal recessive progressive motoneuron disease that is caused by a defect in the riboflavin transporter genes SLC52A2 and SLC52A3. BVVL syndrome has a variable age of presentation, and it is characterized by progressive auditory neuropathy, bulbar palsy, stridor, muscle weakness, and respiratory compromise secondary to diaphragmatic and vocal cord paralysis. BVVL syndrome has a poor prognosis in the absence of treatment, including morbidity with quadriparesis and sensorineural hearing loss, with mortality in the younger age group. Early administration of riboflavin is associated with prolonged survival, low morbidity, and reversal of some clinical manifestations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We describe an 18-month-old male infant with progressive pontobulbar palsy, loss of developmental milestones, and a clinical picture suggestive of chronic inflammatory demyelinating neuropathy. A nerve conduction study revealed axonal neuropathy, while molecular analysis revealed a homozygous mutation in one of the riboflavin transporter genes, SLC52A3, confirming BVVL syndrome. The patient needed long-term respiratory support and a gastrostomy tube to support feeding. With high-dose riboflavin supplementation, he experienced moderate recovery of motor function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This report highlights the importance of considering BVVL syndrome in any patient who presents with the clinical phenotype of pontobulbar palsy and peripheral axonal neuropathy, as early riboflavin treatment may improve or halt disease progression, thus reducing the associated mortality and morbidity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1377515","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T04:33:21Z","timestamp":1714451601000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: A rare treatable metabolic syndrome (Brown-Vialetto-Van Laere syndrome) masquerading as chronic inflammatory demyelinating polyneuropathy from Saudi Arabia"],"prefix":"10.3389","volume":"12","author":[{"given":"Amal Y.","family":"Kentab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"Alsalloum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Labani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar","family":"Hudairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muddathir H.","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dima Z.","family":"Jamjoom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H.","family":"Alwadei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem M.","family":"Alhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad A.","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1750-1172-7-83","article-title":"The Brown-Vialetto-Van Laere and fazio londe syndrome revisited: natural history, genetics, treatment and future perspectives","volume":"7","author":"Bosch","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/00005053-189411000-00003","article-title":"Infantile amyotrophic lateral sclerosis of the family type","volume":"19","author":"Brown","year":"1894","journal-title":"J Nerv Ment Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ajhg.2010.02.006","article-title":"Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54","volume":"86","author":"Green","year":"2010","journal-title":"Am J Hum Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ajhg.2010.05.021","article-title":"Exome sequencing in Brown-Vialetto-Van Laere syndrome","volume":"87","author":"Johnson","year":"2010","journal-title":"Am J Hum Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1093\/brain\/awx231","article-title":"Clinical, pathological and functional characterization of riboflavin-responsive neuropathy","volume":"140","author":"Manole","year":"2017","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jimd.12053","article-title":"An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency","volume":"42","author":"O'Callaghan","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.nmd.2012.05.007","article-title":"Brown-Vialetto-Van Laere and fazio-londe overlap syndromes: a clinical, biochemical and genetic study","volume":"22","author":"Ciccolella","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/0883073816689517","article-title":"Brown-Vialetto-Van Laere syndrome as a mimic of neuroimmune disorders: 3 cases from the clinic and review of the literature","volume":"32","author":"Allison","year":"2017","journal-title":"J Child Neurol"},{"key":"B9","first-page":"51","article-title":"Brown-Vialetto-Van Laere syndrome: a case with anti-ganglioside GM1 antibodies and literature review","volume":"154","author":"Sztajzel","year":"1998","journal-title":"Rev Neurol (Paris)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10545-016-9924-2","article-title":"Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience","volume":"39","author":"Jaeger","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.spen.2017.03.002","article-title":"The first case of riboflavin transporter deficiency in Sub-Saharan Africa","volume":"26","author":"Chaya","year":"2018","journal-title":"Semin Pediatr Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2018.05.005","article-title":"Dramatic improvement of a rare syndrome with high dose riboflavin treatment","volume":"86","author":"Forman","year":"2018","journal-title":"Pediatr Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13073-023-01192-5","article-title":"The clinical utility of rapid exome sequencing in a consanguineous population","volume":"15","author":"Monies","year":"2023","journal-title":"Genome Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"E1976","DOI":"10.1002\/humu.21399","article-title":"Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172B","volume":"32","author":"Ho","year":"2011","journal-title":"Hum Mutat"},{"volume-title":"Riboflavin Transporter Deficiency Neuronopathy","year":"2015","author":"Manole","key":"B15"},{"key":"B16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/brain\/awt315","article-title":"Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2","volume":"137","author":"Foley","year":"2014","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10545-011-9434-1","article-title":"Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)","volume":"35","author":"Horvath","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1172-3-9","article-title":"Brown-Vialetto-Van Laere syndrome","volume":"3","author":"Sathasivam","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1212\/nxg.0000000000000215","article-title":"Late-onset and acute presentation of Brown-Vialetto-Van Laere syndrome in a Brazilian family","volume":"4","author":"Camargos","year":"2018","journal-title":"Neurol Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/mus.24224","article-title":"Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood","volume":"50","author":"Srour","year":"2014","journal-title":"Muscle Nerve"},{"key":"B21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/21678421.2013.837931","article-title":"Brown-Vialetto-Van Laere syndrome: clinical and neuroradiological findings of a genetically proven patient","volume":"15","author":"Bandettini Di Poggio","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejpn.2013.09.006","article-title":"Brown-Vialetto-Van Laere syndrome: a riboflavin responsive neuronopathy of infancy with singular features","volume":"18","author":"Spagnoli","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.pediatrneurol.2012.03.008","article-title":"Brown-Vialetto-Van Laere syndrome: a riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene","volume":"46","author":"Koy","year":"2012","journal-title":"Pediatr Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ajmg.a.38530","article-title":"Riboflavin transporter deficiency mimicking mitochondrial myopathy caused by complex II deficiency","volume":"176","author":"Nimmo","year":"2018","journal-title":"Am J Med Genet A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"a000257","DOI":"10.1101\/mcs.a000257","article-title":"Exome sequencing results in successful riboflavin treatment of a rapidly progressive neurological condition","volume":"1","author":"Petrovski","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e625","DOI":"10.1212\/wnl.0000000000004973","article-title":"Clinical reasoning: siblings with progressive weakness, hypotonia, nystagmus, and hearing loss","volume":"90","author":"Set","year":"2018","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.spen.2017.03.001","article-title":"Genetic, radiologic, and clinical variability in Brown-Vialetto-Van Laere syndrome","volume":"26","author":"Woodcock","year":"2018","journal-title":"Semin Pediatr Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1002\/mus.25694","article-title":"Reversible posterior column dysfunction in Brown-Vialetto-Von Laere syndrome","volume":"56","author":"Khadilkar","year":"2017","journal-title":"Muscle Nerve"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2014.10.016","article-title":"Adult onset Brown-Vialetto-Van Laere syndrome with opsoclonus and a novel heterozygous mutation: a case report","volume":"128","author":"Cosgrove","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1469-8749.2011.04142.x","article-title":"Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome","volume":"54","author":"Anand","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1017\/s0022215110001982","article-title":"Cochlear implantation in Brown-Vialetto-Van-Laere syndrome","volume":"125","author":"Sinnathuray","year":"2011","journal-title":"J Laryngol Otol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1590\/s0004-282-2007000100008","article-title":"A Brazilian family with Brown-Vialetto-Van Laere syndrome with autosomal recessive inheritance","volume":"65","author":"Malheiros","year":"2007","journal-title":"Arq Neuropsiquiatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1377515\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T04:33:24Z","timestamp":1714451604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1377515\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":32,"alternative-id":["10.3389\/fped.2024.1377515"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1377515","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"article-number":"1377515"}}